Jdp Drug Patent Portfolio
Jdp owns 1 orange book drug protected by 5 US patents Given below is the list of Jdp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
Latest Legal Activities on Jdp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Jdp.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 May, 2024 | US8314083 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Feb, 2024 | US8263581 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Feb, 2023 | US9119771 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US8513259 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US9119771 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US8314083 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Jan, 2021 | US8513259 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 15 Apr, 2020 | US8263581 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Apr, 2020 | US8263581 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Apr, 2020 | US8314083 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 11 Nov, 2019 | US8263581 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Oct, 2019 | US9119771 |
|
Email Notification
Critical
| 02 Oct, 2019 | US9119771 |
|
Correspondence Address Change
Critical
| 01 Oct, 2019 | US9119771 |
|
Email Notification
Critical
| 17 Jul, 2019 | US8513259 |
Jdp's Family Patents
Jdp Drug List
Given below is the complete list of Jdp's drugs and the patents protecting them.
1. Quzyttir
Quzyttir is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(4 years from now)
| Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(4 years from now)
| Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(4 years from now)
| Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(4 years from now)
| Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Quzyttir's drug page